PR Newswire Golden Goblet Competition Lineup Announced: Spotlight on the 2026 Contenders by Money Compass May 31, 2026
PR Newswire Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet by Money Compass May 31, 2026
PR Newswire THE KILLERS ROCK THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI® by Money Compass May 30, 2026
PR Newswire THE KILLERS ROCK THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI® by Money Compass May 30, 2026
PR Newswire The Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancet by Money Compass May 30, 2026
PR Newswire Kelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO by Money Compass May 30, 2026
PR Newswire Duke-NUS graduates biggest class yet, with new doctors drawn from business, engineering and the humanities by Money Compass May 30, 2026
PR Newswire The 7th China-CEEC Local Leaders’ Meeting and 2026 Shandong International Friendship Cities Cooperation and Exchange Week Successfully Held by Money Compass May 30, 2026
PR Newswire MakerWorld’s First User-Initiated Charity Contest Names Winners, Bringing Global Creators’ Goodwill Directly to Cancer Wards by Money Compass May 30, 2026
PR Newswire ENERtec Asia 2026 Partners with MIDA to Power Malaysia’s Digital Economy via Renewable Energy and Battery Storage Innovation by Money Compass May 30, 2026